1. Systematic investigation of fabrication conditions of nanocarrier based on carboxymethyl chitosan for sustained release of insulin.
- Author
-
Bai, Xiaoyu, Kong, Ming, Xia, Guixue, Bi, Shichao, Zhou, Zhongzheng, Feng, Chao, Cheng, Xiaojie, and Chen, Xiguang
- Subjects
- *
CARBOXYMETHYL compounds , *INSULIN , *ENCAPSULATION (Catalysis) , *PHYSIOLOGICAL effects of nanoparticles , *GELATION - Abstract
pH-responsive nanoparticles (NPs) comprised of degradable carboxymethyl chitosan (CMCS) crosslinked with CaCl 2 were simply prepared via ionic gelation. Fabrication conditions including insulin dosage, CMCS concentration, and crosslinking density were systematically investigated for insulin loading and release in vitro . The encapsulation efficiencies (EE), loading capacity (LC) and average size of the NPs decreased with the increasing insulin concentrations (<0.192 mg/mL), while they notably increased as the insulin dosage was above 0.192 mg/mL. When the concentration of CMCS increased from 0.5 to 2.0 mg/mL, the EE of the NPs reduced while the size of the NPs increased. We further demonstrated that crosslinking density offered a simple method for tuning the properties of the NPs towards various insulin concentrations. The mass ratio 10:5 of CMCS to CaCl 2 exhibited the optimal performance at higher insulin concentration, whereas a higher crosslinking density of 10:7 (m:m) gave the optimal performance at low insulin concentration. The cumulative release of insulin from insulin loaded NPs decreased with the elevating crosslinking density. These findings not only provided a better understanding of the synthesis of CMCS NPs but also contributed to the practical applications of insulin loading and release. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF